To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
The First World War witnessed an unprecedented scale of amputation. Traditionally, it has been argued that design and innovation were a direct result of the numbers of prostheses required to re-embody the many thousands of amputees from the war. This chapter argues that innovations in artificial limbs were well-established in the nineteenth century. Furthermore, there were a number of reputable companies that maintained a good trade in artificial limbs. The surgical profession and the commercial arena, while aware of each other, operated separately in two spheres. The First World War physically narrowed this division, relocating the limb fitter and the surgeon in close proximity in specialist hospitals established for amputees. Many manufacturers, including some from overseas, were required to provide the amputee servicemen with limbs, yet the relationship between the two professions was not improved. Nevertheless, the specialist hospitals staffed with experts in surgical technique and artificial limb fitting benefitted a number of patients. Focusing on Queen Mary Roehampton Hospital, this chapter explores the relationship between physical spaces and professionals, and the impact that it has on medical care in the First World War.
This chapter explores how the efforts to increase the availability of human organs by moving to an institutional arrangement based on presumed consent necessarily extend beyond shaping people's cultural attitude towards organ donation. Transforming the prevailing cultural attitude and habitual behaviour in respect of organ donation also requires subtle but significant shifts in how people imagine the dead body, the individual and her or his responsibilities to others, and the limits of medicine. The chapter considers the debates in light of the ideas of Michel Foucault about the construction and government of the modern individual. Central to Foucault's conceptualisation of governmentality is that the modern sovereign state and the modern autonomous individual, homo economicus, co-determined each other's emergence. Peter Wehling is ambivalent about the emergence of active biological citizenship, which he regards as a new and significant element in contemporary governmental regimes of medicine.
In 1822, George Webb Derenzy, a former captain in the British army, published a volume titled Enchiridion: Or, A Hand for the One-Handed. The text highlighted what Derenzy called his ‘One-Handed Apparatus,’ a collection of twenty instruments that he had made after losing his arm in the Napoleonic Wars. Designed to ease his daily routines of washing, eating, writing, and socializing, Derenzy’s inventions included, among other items, an egg cup that tilted in any direction and a card-holder that fanned out and folded up for easy transportation. This chapter examines Derenzy’s motivations for publishing the Enchiridion; the responses he received from readers around the globe; and the presuppositions about gender and class that ultimately constrained his consumer appeal and profit. Derenzy chose to publish, not patent, his contraptions due to his charitable desires to share them with others with lost limbs. His focus on using his prostheses to reclaim aspects of his social respectability and manly independence that his impairments seemed to threaten, however, ended up alienating poor, middling, and female patrons and limiting his success as an entrepreneur and a philanthropist. Perhaps due to these marketing missteps, Derenzy experienced the plight of many physically-impaired people during the period; unable to profitably labour, he sustained a steady descent into poverty.
In recent decades, theorists of disability rights have made the moral and legal case for supported decision-making. Whereas surrogate decision-making, the long upheld legal standard, looks to a third party to make a decision for a person deemed to lack the capacity to make that decision for themselves, support in decision-making empowers that person to make their own decisions. In this article, we argue for a significant shift in the norms governing enrollment in clinical trials. Rather than assume that support is only appropriate for individuals who cannot independently make sufficiently informed enrollment decisions, we propose “support in decision-making for all” when research protocols are beyond a certain risk threshold. Drawing inspiration from the universal design movement and feminist insights about autonomy, we argue that making support in decision-making the presumption has substantial expressive and practical benefits, and better empowers all potential research participants to make more informed, autonomous decisions.
As the 2024 Paris Olympic Games approach, it seemed relevant to analyze 25 past years of medical workload at the Stade de France to better predict future needs by identifying the determinants of workload levels.
Methods
Site: Stade de France, the largest French stadium, in the Greater Paris area.
Inclusion: Events from 1998 to 2022.
Parameters: Nature of event; level of event; competition finals; number of spectators, weather, and medical workload.
End-points: Number of patient presentations.
Results
459 events were studied: 167 (36%) football matches, 142 (31%) rugby matches, 111 (24%) artistic performances, 26 (6%) athletics competitions, 11 (2%) motor sports competitions, and 2 (0.5%) other types of events. Median attending spectators: 72,057 [56,825-78,500]. Median patient presentations: 29 (15-59) or 5 (2-9) per 10,000 spectators. Median transports to hospital: 2 (1-3) per event, or 0.3 [0.1-0.5] per 10,000 spectators. Median medicalized transports to hospital: 0 [0-0] per event. The nature of the event, rugby (OR = 7.97 [1.65-46.80]), international event (0.18 [0.04-0.76]), and temperature (OR = 0.86 [0.77-0.96]) were associated with a greater frequency of high medical workload in multivariate analysis.
Conclusion
Rugby matches, level of event, and outdoor temperature were independent determinants of medical workload. Number of spectators and duration of the event had no influence.
In the US, cardiovascular diseases (CVD) are the leading cause of death and disability. Cost-related medication non-adherence (CRMN) can have serious consequences and worsen CVD outcomes. We examined the relationship between CVD risk factors and CRMN among US adults.
Methods:
CDC’s 2019–2021 National Health Interview Survey (NHIS) data were used to examine CRMN among adults, categorized into three groups based on reported risk factors. We used chi-square tests, and logistic regression to determine factors associated with CRMN.
Results:
Among 49,464 participants, young, unmarried individuals, females, less educated, and participants from the South had higher CRMN than older, married individuals, males, and those with higher education residing in the other regions. Current smokers and those with more CVD risk factors also reported higher CRMN than former and never-smokers. Conversely, those aged 65 or older, with high-income, and excellent self-rated health had lower CRMN than younger participants, low-income families, and those with poor self-rated health. Public insurance and Medicaid participants had lower CRMN than uninsured (OR 0.13, 95% CI, 0.04–0.45, and OR 0.24, 95% CI, 0.15–0.36). Stratified analysis by diabetes, hypertension, and hyperlipidemia, revealed participants with high-income had lower odds of CRMN (OR 0.38, 95% CI, 0.28–0.50; OR 0.39, 95% CI, 0.28–0.58; OR 0.37, 95% CI, 0.27–0.51 respectively) than those with lower- incomes.
Conclusion:
Adults under 65 with more CVD risk factors and lacking insurance coverage are at higher risk of CRMN. Therefore, strengthening prescription drug coverage and targeted interventions are necessary to reduce CRMN among those with cardiovascular risk factors.
To describe the development, delivery, and outcome of an action-oriented intervention comprising an awareness-raising educational video and workshop designed to support general practice teams to identify and plan decarbonization actions, delivered from May-September 2024.
Background:
Healthcare services internationally are committing to net zero targets. General practice is recognized as having a pivotal role in achieving these ambitions. However, limited awareness of decarbonization initiatives and insufficient support for implementation highlight the need for an educational resource to facilitate action planning.
Methods:
Principles of organizational change, video-design, and barriers to decarbonization informed the intervention’s development. The video included modules featuring resource materials and ideas to support the development and implementation of decarbonization actions in general practice. Prompts for a facilitated workshop discussion were developed to support action planning. The intervention was delivered to 64 multidisciplinary staff across 12 general practices in England. A conceptual content analysis was conducted on completed practice green action plans (GAPs) and data from an online participant feedback form were analysed using descriptive statistics to assess perceptions of the intervention. Free-text comments were thematically analysed.
Results:
Across the 12 GAPs, each practice planned between three and eight decarbonization actions. ‘Managing waste’ was the most frequently addressed area, appearing in 10 practice GAPs, and most planned actions mapped onto those presented within the video. Thirty (46.9%) participants completed the evaluation survey. The intervention was well received, with 28 (93.3%) survey respondents rating the overall usefulness of the video as 4 or 5 (1 ‘not at all useful’ to 5 ‘very useful’). Free-text comments for suggested improvements related to time for consolidating learning, and concerns about the video’s audio quality and duration.
Conclusions:
The educational workshop successfully facilitated the development of structured GAPs with explicit timescales and intended outcomes. This study did not assess the implementation of planned actions.
Oxeiptosis is a reactive oxygen species (ROS)-dependent form of programmed cell death that plays a key role in cellular homeostasis and holds promise as a cancer therapy. This review explores its molecular mechanisms, emphasizing the KEAP1–PGAM5–AIFM1 signalling pathway and its reliance on ROS accumulation. Compared to other cell death pathways, oxeiptosis offers a distinct approach, especially for targeting cancer cells resistant to conventional therapies. The review evaluates emerging inducers, both synthetic and natural, that selectively trigger oxeiptosis in cancer cells. It also examines the potential synergy between oxeiptosis and ROS-generating chemotherapies, particularly in the oxidative tumour microenvironment. However, challenges remain, including identifying tumour-specific inducers, overcoming cancer cell resistance to oxidative stress and reducing off-target effects. The review concludes by highlighting the need for targeted delivery strategies and rigorous preclinical studies to translate oxeiptosis into effective cancer treatments. Overall, it underscores oxeiptosis as a promising avenue to address drug resistance and improve therapeutic outcomes in oncology.
While supported decision-making for persons with dynamic cognitive impairment has been considered in the context of medical treatment, there has been little attention to its application in the context of enrolling cognitively impaired subjects in clinical research. The Common Rule allows enrollment permission from a Legally Authorized Representative, one empowered under institutional policy to provide consent for subjects lacking decision-making capacity, but many Legally Authorized Representatives lack knowledge of the person’s values and preferences adequate to an ethically valid judgement about research enrollment. Supported decision-making and surrogate decision-making can be complementary as subjects transition between impairment stages, providing an opportunity to address ethical problems with the current practice of reliance on uninformed surrogates. Through designation of a supporter who is willing to serve through the progression of impairment, dementia patients choose their supporter and ultimate surrogate, engage with them on the issues that later give rise to requests to enroll the subject in research, and ensure that the surrogate will have knowledge of the values and preferences of the subject necessary to an ethically defensible substituted judgement. Legal frameworks can be adapted to provide recognition of research enrollment as an area of valid decision by supporters on behalf of beneficiaries.
To examine the prevalence, financial value and marketing leveraging methods of food sponsorship agreements and food service contracts in Canadian recreation and sport facilities (RSF).
Design:
Cross-sectional survey using descriptive analysis. RSF managers and directors reported the number, value and types of marketing leveraging methods used in food-related sponsorship agreements and food service contracts.
Setting:
Publicly funded RSF in nine Canadian provinces that provide indoor sport programming for children and youth.
Participants:
Eighty-six RSF representatives completed the survey (response rate: 73·9 %). Most facilities were municipally owned and located in urban settings; over 70 % served children under 13 years of age.
Results:
Food sponsorship agreements and food service contracts were reported by 36·5 % and 65·5 % of RSF, respectively. Financial donations were included in 88·6 % of sponsorship agreements and 27·4 % of contracts. Sponsors contributed a median of 25·0 % (IQR: 13·9–83·3 %) of total sponsorship income, with a median annual donation per sponsor of $500 (IQR: $288–$1375). Nearly all agreements and contracts included at least one food marketing leveraging method. Branded signage was the most common in sponsorship agreements (64·6 %), while equipment donation was the most common in food service contracts (52·2 %).
Conclusions and Implications:
Food sponsorship and service agreements are prevalent in Canadian RSF and include financial and in-kind contributions that may benefit facilities. However, the marketing leveraging methods used – such as branded signage and product provision – may also increase children’s exposure to food marketing. Greater monitoring and evaluation of these marketing practices are needed, especially in the context of proposed national marketing restrictions.
Federal disability anti-discrimination laws expect clinical trials to render study processes and sites accessible to potential participants, including through the provision of reasonable accommodations. Nonetheless, people with disabilities, and particularly people with mental illness, are often excluded from clinical trials. Supported decision-making, a strategy that allows people to select trusted others to help them understand and communicate decisions, is an important accommodation to further inclusion. However, because mental illness can be dynamic and vary widely in nature (e.g., diagnosis, symptom severity, functional impairment) and duration (e.g., short-term, intermittent, progressive, permanent), supported decision-making is neither a one-size-fits-all strategy nor one that can serve as a reasonable accommodation in every situation. While prior work on supported decision-making has focused predominantly on adults with intellectual and developmental disabilities or dementias, people with mental illness may also benefit from supported decision-making, although the variability in decision-making capacity in mental illness presents nuanced challenges. Here, we explore supported decision-making in the case of people with intermittent or episodic mental illness that may impact decision-making capacity to varying degrees at different times.
Hypoxia is a defining feature of the tumour microenvironment (TME) that drives aggressive tumour behaviour through coordinated adaptive responses. Hypoxia-inducible factors (HIFs), particularly HIF-1α, play a central role in orchestrating metabolic, immune and epigenetic reprogramming within tumours.
Objective
This review aims to elucidate the integrated roles of hypoxia in regulating angiogenesis, immune suppression, metabolic adaptation and epigenetic modifications, and to highlight their collective impact on tumour progression and therapeutic resistance.
Methods
A comprehensive review of current literature was conducted to examine the molecular and cellular mechanisms mediated by hypoxia and HIF signalling within the TME, with a focus on their interplay across angiogenic, immune, metabolic and epigenetic pathways.
Results
HIF-1α promotes the expression of pro-angiogenic factors, including VEGF, ANGPT2 and CXCL12, leading to abnormal vascularisation and recruitment of immunosuppressive cells such as regulatory T cells and myeloid-derived suppressor cells. This disorganised vasculature exacerbates hypoxia, reinforcing a cycle of immune evasion and metabolic stress. Hypoxia also upregulates immune checkpoint molecules (e.g., PD-L1, PD-1), contributing to T-cell exhaustion and impaired dendritic cell function. Concurrently, metabolic reprogramming—characterised by increased glycolysis, lactate accumulation and extracellular acidification—suppresses cytotoxic T cell and NK cell activity. Epigenetic regulators, including histone demethylases and DNA methyltransferases, sustain these adaptations through persistent transcriptional changes, referred to as hypoxic memory.
Conclusion
Hypoxia acts as a central organising force within the TME, coordinating angiogenic, immune, metabolic and epigenetic processes to promote tumour progression. Targeting HIF-driven pathways represents a promising therapeutic strategy to overcome immune resistance, enhance drug delivery and improve the efficacy of combination treatments, including immunotherapy and metabolic interventions. This review underscores the importance of integrated approaches to disrupt hypoxia-mediated tumour adaptation.
This chapter explores the Assessment of Need (AoN) process as a governmental technology which literally brings into being a new classification of people with disabilities and their assessed needs as governable entities. Governmentality literature has provided a fruitful hunting ground in terms of finding conceptual tools to analyse the ways in which states problematise and govern 'the wealth, health and happiness of populations'. Ireland has witnessed significant developments in the domain of disability policy and legislation. In a declared commitment to furthering the participation of people with disabilities in society, the government published a National Disability Strategy in 2004, the cornerstone of which was the passing of the Disability Act 2005. The chapter explores the spaces in-between the rationalities of particular policy programmes on the one hand, and the end point of many Foucauldian studies, namely the creation of self-governing subjects, on the other.